Literature DB >> 7678911

Assessment of the relation between the initial viability and the attachment of freshly isolated rat hepatocytes used for the in vivo/in vitro DNA repair assay (UDS).

R Fautz1, B Husein, E Efstathiou, C Hechenberger-Freudl.   

Abstract

Crucial steps of the in vivo/in vitro DNA repair assay (UDS) are the hepatocyte isolation procedure and the establishment of the hepatocyte cultures. Since the attachment of the isolated hepatocytes on the surface of the culture vessel is an essential prerequisite for the in vitro part of this assay to yield scorable autoradiograms, we assessed the relation between the initial viabilities of hepatocyte preparations and the resulting attachment efficiencies from 286 rats. The initial viability was determined by means of the trypan blue dye exclusion assay. The actual cell number was corrected for the viability and a constant number of 2.5 x 10(5) viable cells were seeded into each well of gelatinized six-well dishes. The amount of adherent cells was determined after a 1.5-h attachment period using a recently described modification (Fautz et al., 1991) of the neutral red dye absorption assay. The attachment is described by the optical density at 540 nm obtained after the elution of neutral red from the adherent cells (OD540 value). To facilitate a comparison of the data we divided the 286 animals into eight arbitrary viability groups. The mean values of the viability groups were 53.1, 62.2, 66.3, 68.4, 70.9, 73.6, 76.9, and 84.0% living cells. Although there was a great interindividual variation, the resulting mean OD540 values were nearly uniform, about 0.5, in all eight groups, regardless of the initial viability of the hepatocytes. UDS data obtained from 46 animals treated with the positive control chemical 2-acetylaminofluorene demonstrated that there was no correlation between the in vitro DNA repair capacity and the initial viability or the attachment efficiency of the hepatocytes. Our results suggest that (i) great interindividual differences exist between the attachment of particular cell preparations with no regard to the initial viability, (ii) the correction of the cell number for viability leads to relatively uniform OD540 mean values and (iii) for an in vivo/in vitro UDS assay even cell suspensions with relatively low viabilities can be used since they will yield adherent cultures which are capable of DNA repair synthesis. The latter item often allows a reduction in the number of animals required for this in vivo assay because it is not necessary to perform repeated experiments because of low viability preparations.

Entities:  

Mesh:

Year:  1993        PMID: 7678911     DOI: 10.1016/0165-1161(93)90013-p

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  The presence of human immunodeficiency virus type 1 Vpr correlates with a decrease in the frequency of mutations in a plasmid shuttle vector.

Authors:  J B Jowett; Y M Xie; I S Chen
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Effects of neutral red assisted viability assessment on the cryotolerance of isolated bovine preantral follicles.

Authors:  A Langbeen; E P A Jorssen; N Granata; E Fransen; J L M R Leroy; P E J Bols
Journal:  J Assist Reprod Genet       Date:  2014-10-02       Impact factor: 3.412

3.  Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein.

Authors:  S Y Kao; S J Marriott
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Hepatitis B virus X protein interferes with cellular DNA repair.

Authors:  S A Becker; T H Lee; J S Butel; B L Slagle
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  A novel purified Lactobacillus acidophilus 20079 exopolysaccharide, LA-EPS-20079, molecularly regulates both apoptotic and NF-κB inflammatory pathways in human colon cancer.

Authors:  Nehal M El-Deeb; Abdelrahman M Yassin; Lamiaa A Al-Madboly; Amr El-Hawiet
Journal:  Microb Cell Fact       Date:  2018-02-21       Impact factor: 5.328

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.